Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
InnoCare Pharma (OTC : INCPF) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. Its commercial drug candidate is Orelabrutinib and clinical-stage drug candidates are ICP-192, ICP-105, ICP-723, and others.
Quote
| Last: | $1.55 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $1.55 |
| Close: | $1.55 |
| High: | $1.55 |
| Low: | $1.55 |
| Volume: | 1,000 |
| Last Trade Date Time: | 02/23/2026 09:30:00 am |
Stock Data
| Market Cap: | $511,942,628 |
|---|---|
| Float: | 249,728,111 |
| Insiders Ownership: | N/A |
| Institutions: | 103 |
| Short Percent: | N/A |
| Industry: | Pharmaceuticals |
| Sector: | Healthcare |
| Website: | https://www.innocarepharma.com |
| Country: | CN |
| City: | Beijing |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about InnoCare Pharma (OTC: INCPF).
